Skip to main content
Premium Trial:

Request an Annual Quote

Intertek Acquires ScanBi Diagnostics

NEW YORK(GenomeWeb) – Multinational testing services firm Intertek today announced it has acquired Swedish agricultural biotechnology firm ScanBi Diagnostics.

"Acquiring ScanBi Diagnostics is a significant enhancement to Interek's food an agricultural expertise and portfolio," Valentin Rossel, global agricultural services business line leader at Intertek, said in a statement. "By adding ScanBi Diagnostic's proven capabilities in testing, molecular biology, analytical testing, species identification, and other biotechnology expertise to our range of services, Intertek is expanding into new global markets."

Financial terms of the deal were not disclosed. Intertek has also acquired 50 percent ownership of Canadian agricultural testing firm Lynx Diagnostics as part of the transaction.

London-based Intertek provides auditing, inspection, testing, training, advisory, quality assurance, and certification for a variety of industries around the world.

Intertek will retain all ScanBi management and staff to continue business operations. The Malmo, Sweden-based firm provides DNA- and protein- based analysis and testing services to Nordic and international clients in the breeding, agricultural, agro-biotech, food and feed industries. ScaniBi's expertise includes genetically modified organism testing, genotyping, pathogen testing, and species identification, Intertek said.

"Intertek will enable us to more easily grow our business into new markets and service niches," Anders Dahlqvist, CEO of ScanBi, said. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.